Circulating Tumor Cells Market Top Players, Segments, Cost Structure, Demand by 2030| Top Industry Leaders Apocell, Vitatex Inc.

 

Circulating Tumor Cells Market Growth & Trends

The global circulating tumor cells market size is expected to reach USD 27.55 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 13.34% from 2023 to 2030. Many potential applications of circulating tumor cells (CTCs) in pre-diagnosis, pretreatment, and intra- and post-treatment provide lucrative growth opportunities to players involved in the development of CTC enrichment and isolation products. Research organizations are involved in activities, which are aimed at developing CTC-based tests to improve cancer diagnosis in terms of efficiency and speed. Furthermore, the growing demand for personalized medicines and growing research for drug development is anticipated to tailor treatment for individuals at the genetic and molecular levels. For instance, according to the research study conducted by Indiana University School of Medicine in October 2021, the presence of CTC and circulating tumor DNA (ctDNA) in the plasma of women who have received pre-surgery chemotherapy for triple-negative breast cancer is one of the important indicators to predict disease recurrence. Thus, these factors are anticipated to drive the market growth over the forecast period.

Moreover, the rising demand for minimally invasive diagnostic treatments is anticipated to impel funds from key stakeholders in this area. CTC-based liquid biopsy tests lead to limited trauma and allow speedy recovery attributing to its non-invasive nature. Furthermore, it assists in minimally invasive screening of cancer formerly opting for complicated surgical treatments, which include surgical removal of tumors, chemotherapy, and radiotherapy, thus positively impacting the adoption of circulating tumor cells.

The limited applicability of these cells in rare cancers has hampered revenue growth to a certain extent. Circulating tumor cells are not applicable to tumors characterized by EpCAM negativity or low expression, such as neurogenic cancers. For instance, there is negligible evidence for the characterization of circulating tumor cells for sarcoma. Conversely, numerous methods are being studied for the isolation of these cells, which include methods based on epithelial antigen-targeted antibodies, anticipating to overcome these challenges in the coming years.

However, in recent years there has been a push for practical application, largely as a result of a wave of large players centralizing the technology through acquisitions and numerous partnerships with pharmaceutical firms to advance the formation of a value chain and speed up market growth. For instance, in June 2023, to develop a novel test for the detection of tumor cells that metastatic cancers shed into the blood, the University of Washington School of Medicine collaborated with RareCyte, Inc. which is a biotech company headquartered in Seattle. In addition, according to the research, the understanding of the circulating tumor cells in the bloodstream can track the changes in tumor cells, thus optimizing the treatment.

Request a free sample copy or view report summary: Circulating Tumor Cells Market Report

Circulating Tumor Cells Market Report Highlights

• Based on the technology, the CTC detection & enrichment methods dominated the market in 2022 with a revenue share of 65.3%owing to the increased availability of products for CTC enrichment and isolation as well as high usage and product penetration across the globe
• The growing application potential of CTC analysis for investigational research, drug development, and biomarker studies will result in the segment's highest CAGR from 2023 to 2030
• Based on application, the research segment accounted for the largest share in 2022 and is projected to grow at the fastest CAGR during the forecast period. This is attributed to the growing number of research studies for better treatment of cancer
• Based on product, the devices and systems segment dominated the market with a revenue share of 43.0% in 2022 owing to the presence of highly efficient automated systems and high usage of systems for the detection of tumor cells
• The whole blood specimens are the key source of circulating tumor cells. As a result, the segment has accounted for the largest revenue share of 46.5% in 2022. The blood specimen segment is also projected to exhibit a significant growth rate during the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-circulating-tumor-cells-market

Circulating Tumor Cells Market Segmentation

Grand View Research has segmented the global circulating tumor cells market based on technology, application, product, specimen, and region:

Circulating Tumor Cells Technology Outlook (USD Million, 2018 - 2030)

• CTC Detection & Enrichment Methods
  • Immunocapture (Label-based)
    • Positive Selection
    • Negative Selection
  • Size-based Separation (Label-free)
    • Membrane-based
    • Microfluidic-based
  • Density-based Separation (Label-free)
  • Combined Methods (Label-free)
• CTC Direct Detection Methods
  • SERS
  • Microscopy
  • Others
• CTC Analysis

Circulating Tumor Cells Application Outlook (USD Million, 2018 - 2030)

• Clinical/Liquid Biopsy
  • Risk Assessment
  • Screening and Monitoring
• Research
  • Cancer Stem Cell & Tumorogenesis Research
  • Drug/Therapy Development

Circulating Tumor Cells Product Outlook (USD Million, 2018 - 2030)

• Kits & Reagents
• Blood Collection Tubes
• Devices or Systems

Circulating Tumor Cells Specimen Outlook (USD Million, 2018 - 2030)

• Blood
• Bone Marrow
• Other Body Fluids

Circulating Tumor Cells Regional Outlook (USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Circulating Tumor Cells Market

• QIAGEN
• Bio-Techne Corporation
• Precision for Medicine
• AVIVA Biosciences
• BIOCEPT, Inc.
• BioCEP Ltd.
• Fluxion Biosciences, Inc.
• Greiner Bio One International GmbH
• Ikonisys Inc.
• Miltenyi Biotec
• IVDiagnostics
• BioFluidica
• Canopus Bioscience Ltd.
• Biolidics Limited
• Creativ MicroTech, Inc.
• LungLife AI, Inc.
• Epic Sciences
• Rarecells Diagnostics
• ScreenCell
• Menarini Silicon Biosystems
• LineaRx, Inc. (Vitatex, Inc.)
• Sysmex Corporation
• STEMCELL Technologies, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Regenerative Medicine Market to Observe Strong Development by 2030|Top Industry Players Integra LifeSciences Corporation

 

Regenerative Medicine Market Growth & Trends

The global regenerative medicine market size is expected to reach USD 90.01 billion by 2030, expanding at a CAGR of 16.79% from 2024 to 2030, according to a new report by Grand View Research, Inc. The presence of a strong pipeline is one of the major drivers in the regenerative medicine market. Companies invest heavily in R&D to upgrade their products with the latest technology and fulfil the unmet needs of their customers.

Furthermore, with the increasing demand for disease treatment therapies, companies have focused their efforts to accelerate R&D for gene therapies that target the cause of disease at a genomic level. The cell and gene therapies in the U.S. pipeline programs (Phase I-III trials) grew from 289 in 2018 to 362 by 2019 according to the data published by PhRMA. This represents an increase of 25% in a single year. Continuous advancements in this field would further boost the demand for regenerative medicines.

Technological advancements such as stem cells, tissue engineering, and nanotechnology has made regenerative medicines a highly interdisciplinary in field. Stem cells are undifferentiated cells, which have the capability to repair and/or regenerate into other cells such as cartilage, tendons, ligaments, muscle, and bones. In July 2021, BlueRock Therapeutics received FDA approval for its pluripotent stem cell-derived dopaminergic neuron therapy, DA01, for advanced Parkinson’s disease treatment. This approval was expected to expand the company’s offerings.

Several key players are taking strategic initiatives such as new product development, strategic alliances, and others have contributed to the regenerative medicine market growth. For instance, in November 2021, Astellas Pharma, Inc. entered into an agreement with Pantherna Therapeutics GmbH to study mRNA-based regenerative medicine. Under this initiative, Astellas' high drug discovery capabilities and Pantherna's state-of-the-art mRNA platform will be used to promote research on developing a new program. In addition, in May 2021, Bayer AG entered into a collaboration with Senti Bio for gene circuit-engineered cell therapies development for regenerative medicine.

Request a free sample copy or view report summary: Regenerative Medicine Market Report

Regenerative Medicine Market Report Highlights

• The therapeutics segment held the largest share in the regenerative medicine market, owing to the growing aging population coupled with an increasing rate of age-related disorders.
• The rise in a number of clinical trials for stem cell and tissue-based regenerative therapies along with an increase in demand for regenerative therapies is expected to positively influence the growth of the market.
• Stem cell and progenitor cell-based therapies are projected to witness significant growth owing to huge investments in the R&D space and a growing number of stem cell banks
• North America dominated the market in 2023 owing to the presence of a significant number of research organizations and universities which are working on R&D of stem cell-based therapies.
• Asia Pacific is anticipated to witness the fastest growth in the coming years owing to the rapid adoption of cell-based methods in the healthcare industry.
• By therapeutic category, the oncology segment dominated the segment in 2023 owing to the increasing cases of cancer globally which is rising the demand for better solutions. The growing number of robust pipelines is driving the market growth.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-regenerative-medicine-market

Regenerative Medicine Market Segmentation

Grand View Research has segmented the global regenerative medicine market based on product, therapeutic category, and region:

Regenerative Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)

• Therapeutics
  • Primary Cell-based Therapeutics
    • Dermatology
    • Musculoskeletal
    • Surgical
    • Dental
    • Others
  • Stem Cell & Progenitor Cell-based Therapeutics
    • Autologous
    • Allogenic
    • Others
  • Cell-based Immunotherapies
  • Gene Therapies
• Tools
• Banks
• Services

Regenerative Medicine Therapeutic Category Outlook (Revenue, USD Million, 2018 - 2030)

• Dermatology
• Musculoskeletal
• Immunology & Inflammation
• Oncology
• Cardiovascular
• Ophthalmology
• Others           

Regenerative Medicine Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Regenerative Medicine Market

• AstraZeneca plc
• Hoffmann-La Roche Ltd.
• Integra Lifesciences Corp.
• Astellas Pharma, Inc.
• Cook Biotech, Inc.
• Bayer AG
• Pfizer, Inc.
• Merck KGaA
• Abbott
• Vericel Corp.
• Novartis AG
• GlaxoSmithKline (GSK)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Durable Medical Equipment Market is Estimated To Reach A Valuation of $331.14 Billion by 2030: Grand View Research Inc.

 Durable Medical Equipment Market Growth & Trends

The global durable medical equipment market size was valued at USD 331.14 billion in 2030 and is projected to grow at a compound annual growth rate (CAGR) of 5.90% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by a rise in chronic diseases, such as kidney failure and cancer. Moreover, technological advancements along with a strong reimbursement scenario are likely to boost the durable medical equipment (DME) market over the forecast period.

The growing geriatric population across the globe is likely to contribute to the industry expansion. People aged 60 years or above are more prone to health issues, such as diabetes, mobility issues, Cardiovascular Diseases (CVDs), and other lifestyle problems. This creates demand for DME products. However, stringent regulatory guidelines in developed economies and a lack of skilled professionals may limit the market growth.

The COVID-19 pandemic has initially affected the market due to the shortage of supply of the product. The market players have resulted in a decline in operations, sales, and revenue during the pandemic. The outbreak has temporarily changed the customer’s spending habits due to the restrictions imposed by the government. The pandemic has resulted in rising costs of the product and post-sale services for the recovery of financial loss incurred by the market players.

The availability of technologically advanced products has also played an important role in positively impacting the growth of the market. Countries such as U.S., UK, and Germany are innovators and early adopters of advanced technologies, thus these are the most important customers for medical device markets with rapid technological innovations. Technological breakthroughs concentrating on increasing efficiency are expected to occur during the forecast period, thereby driving market growth.

Request a free sample copy or view the report summary: Durable Medical Equipment Market Report

Durable Medical Equipment Market Report Highlights

• Monitoring and therapeutic devices emerged as the largest segment owing to the launch of technologically advanced products with more comfort and portability.
• Home healthcare is anticipated to be the fastest-growing segment in the forecast period as it is less expensive and preferred by aged people.
• North America led the market with the largest share in 2022 and will witness steady growth in the future on account of the presence of major companies in the region.
• Asia Pacific is expected to register the highest CAGR in the forecast period owing to the presence of a large target population base and improving healthcare facilities.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-durable-medical-equipment-dme-market

Durable Medical Equipment Market Segmentation

Grand View Research has segmented the durable medical equipment (DME) market report based on product, end use, and region:

Durable Medical Equipment Product Outlook (Revenue, USD Million; 2018 - 2030)

• Personal Mobility Devices
  • Wheelchairs
  • Scooters
  • Walker and Rollators
  • Cranes and Crutches
  • Door Openers
  • Other Devices
• Bathroom Safety Devices and Medical Furniture
  • Commodes and Toilets
  • Mattress & Bedding Devices
• Monitoring and Therapeutic Devices
  • Blood Sugar Monitors
  • Continuous Passive Motion (CPM)
  • Infusion Pumps Market
  • Nebulizers
  • Oxygen Equipment
  • Continuous Positive Airway Pressure (CPAP)
  • Suction Pumps
  • Traction Equipment
  • Others Equipment

Durable Medical Equipment End Use Outlook (Revenue, USD Million; 2018 - 2030)

• Hospitals
• Nursing Homes
• Home Healthcare
• Other End-user

Durable Medical Equipment Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in Durable Medical Equipment Market

• Invacare Corporation
• ArjoHuntleigh
• Stryker Corporation
• Hill Rom, Inc.
• Drive Medical
• GF Health Products, Inc.
• Sunrise Medical
• Medline Industries
• Hill Rom, Inc.
• Carex Health Brands, Inc
• Becton, Dickinson and Company
• General Electric Company
• Medtronic PLC
• Compass Health Brands
• Getinge AB
• Resmed Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Stem Cells Market is Poised to Exhibit A Moderate 9.74% CAGR through 2030

 

Stem Cells Market Growth & Trends

The global stem cells market size is expected to reach USD 31.6 billion by 2030, registering a CAGR of 9.74% from 2023 to 2030, according to a new report by Grand View Research, Inc. Stem cells are cells that can differentiate into a variety of other cells, eventually forming organs or tissues. Many studies have been conducted over the years to assess the true potential of stem cells, leading to a variety of applications in the fields of genetic disease treatment, neurological disorders, oncology, and organ regeneration. The market is driven by the rising number of banks, growing focus on increasing therapeutic potential of these products, and extensive research for the development of regenerative medicines, among other factors.

The growing focus on regenerative therapies is fueling market expansion. iPSCs are becoming increasingly popular for the creation of customized cellular therapies, and opening up new possibilities in regenerative medicine. For instance, in September 2020, researchers from Duke-NUS and Monash University discovered the first stem cell that can aid in the treatment of placenta issues during pregnancy. The researchers devised a new method for producing induced trophoblast stem cells that can be used to generate placenta cells. The research will aid in the development of an in-vitro human placenta model and pave the way for future therapies.

Moreover, COVID-19 is acting as a catalyst for promoting the market growth. Several countries such as U.S., China, and Iran, have started conducting clinical trials using cellular therapies for treatment of COVID-19 infections. Furthermore, the use of cell therapy in the treatment of COVID-19 patients has yielded excellent results, which is fueling market expansion. In January 2020, a group of researchers in Beijing, China, tested stem cell treatment on patients to see if it was beneficial against COVID-19. The study found that administering intravenous clinical-grade MSCs to COVID-19 patients during first trial of treatment, improved their functional results and promoted enhanced recovery. 

Increasing prevalence of cancer is one of the key factors contributing to the growth over the forecast period. Failure of combination therapy and chemotherapy for treatment of cancer has led to the shift in preference of physicians from such therapies to autologous and allogeneic stem cell therapy, thereby boosting the growth. Moreover, key market players and the government bodies are continuously investing in cancer research. For instance, in November 2021, California Institute for Regenerative Medicine invested USD 4 million in therapy targeting patients with acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) 

Introduction of novel technologies for the usage and adoption of cell based therapy is expected to boost the growth over the forecast period. Automation in adult stem cell & cord blood processing and storage are the key technologies expected to positively influence the market growth. For instance, various scientists are aiming for the approval of safe, and successful treatments using stem cells in a broad range of diseases. In 2021, companies such as Biotech Cellino invested USD 75 million in an effort to merge Artificial Intelligence technology for the development of automated stem cell manufacturing, that has the ability to regularizing access to cell treatments while aiming to be cost effective. 

On the other hand, high cost of therapy is expected to hinder the market growth. For example, Bio informant, a stem cell research firm, reported that the cost of stem cell therapy ranges between USD 5,000 and USD 8,000 per patient, with some cases costing as much as USD 25,000 or more depending on the complexity of the procedure. Furthermore, restrictions on stem cell research activities have traditionally hampered embryonic stem cell growth, resulting in a meager share of the total market despite its advantages. 

Request a free sample copy or view report summary: Stem Cells Market Report

Stem Cells Market Report Highlights

• ASCs segment accounted for the largest share in 2022 as it is considered as a gold standard in stem cell-based therapies. They are widely accepted owing to their consistent clinical success especially in hematopoietic transplants and there is a relatively less controversial view regarding their origin
• The iPSC segment is expected to witness a lucrative CAGR through 2023-2030 owing to the increasing focus of companies in using iPS for cell therapies. For instance, in July 2020, Cynata Therapeutics Limited announced positive results for the phase 1 clinical trial of CYP-001, the company’s lead iPSC derived Cymerus
• Regenerative medicine dominated the market in 2022 owing to increasing funding by the government for the development of regenerative medicines. For instance, in October 2020, the AusBiotech-led consortium received funding of USD 300,000 from MTPConnect’s Industry Growth Centre Project Fund for the development of regenerative medicines in Australia
• Cell acquisition technology held the largest market share in 2022 and is expected to expand at the fastest CAGR through 2023-2030 owing to increasing research studies involving cell harvesting
• Allogenic therapy dominated the market in 2022 owing to the increasing application of allogeneic stem cell transplants for cancer treatment
• Pharmaceutical and biotechnology companies held the largest market share in 2022, and is anticipated to exhibit at fastest CAGR owing to upsurge in R&D, increasing clinical trials coupled with strategic activities by major market players
• North America market encompasses U.S. and Canada. The factors contributing to the market growth in the region include robust government funding, increasing research, and the presence of prominent players in this region
• Asia Pacific is expected to grow with the fastest CAGR of through 2023 to 2030 owing to increasing expansion by key companies in this region. For instance, in April 2020, Seneca Biopharma completed its new stem cell manufacturing facility in Suzhou, China 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-stem-cells-market

Stem Cells Market Segmentation 

Grand View Research has segmented the global stem cells market based on product, technology, application, therapy, end-user, and region:

Stem Cells Product Outlook (Revenue, USD Million, 2018 - 2030)

• Adult Stem Cells (ASCs)
  • Hematopoietic
  • Mesenchymal
  • Neural
  • Epithelial/Skin
  • Others
• Human Embryonic Stem Cells (HESCs)
• Induced Pluripotent Stem Cells (iPSCs)
• Very Small Embryonic Like Stem Cells

Stem Cells Application Outlook (Revenue, USD Million, 2018 - 2030)

• Regenerative Medicine
  • Neurology
  • Orthopedics
  • Oncology
  • Hematology
  • Cardiovascular and Myocardial Infraction
  • Injuries
  • Diabetes
  • Liver Disorder
  • Incontinence
  • Others
• Drug Discovery & Development

Stem Cells Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Cell Acquisition
  • Bone Marrow Harvest
  • Umbilical Blood Cord
  • Apheresis
• Cell Production
  • Therapeutic Cloning
  • In-vitro Fertilization
  • Cell Culture
  • Isolation
• Cryopreservation
• Expansion And Sub-Culture

Stem Cells Therapy Outlook (Revenue, USD Million, 2018 - 2030)

• Autologous
• Allogenic

Stem Cells End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies
• Hospitals & Cell Banks
• Academic & Research Institutes

Stem Cells Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in Stem Cells Market

• Advanced Cell Technology Inc.
• STEMCELL Technologies Inc.
• Cellular Engineering Technologies Inc.
• CellGenix GmbH       
• PromoCell GmbH
• Kite Pharma   
• Lonza 
• Cellartis AB
• Angel Biotechnology
• Brainstorm Cell Therapeutics
• Celgene Corporation
• Osiris Therapeutics
• Genea Biocells
• Bioheart Inc.
• Waisman Biomanufacturing
• Tigenix
• Caladrius Biosciences
• Gamida Cell

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Astaxanthin Market Latest Innovations, Drivers and Industry Key Events 2024 – 2030: Grand View Research Inc.

 Astaxanthin Market Growth & Trends

The global astaxanthin market size is expected to reach USD 7.28 billion by 2030, set to grow at a 17.1% CAGR from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for nutraceuticals and growing applications of carotenoids in the animal feed industry & aquaculture are the major factors driving the market growth. Moreover, the rapidly aging population and the growing health awareness among consumers are likely to support market expansion.

The market is anticipated to witness growth opportunities owing to growth in the aquaculture and fishing sectors. For instance, Germany is expanding its fish production and according to the federal statistical office of Germany, the country produced around 18,300 tons of fish in 2021. The growth in the aquaculture sector across the globe is likely to propel the demand for astaxanthin as the pigment helps to boost the immunity of animals and enhance the pigmentation of aquatic animals, such as ornamental fish, and rainbow trout.

Moreover, the market growth is also fueled by various research & development activities to increase the adoption of astaxanthin. For instance, in December 2021, AstaReal and the University of Tsukuba announced a new patent and research showing that the astaxanthin molecules modulate the genes of the brain involved in neuron formation, memory, and learning. Moreover, in July 2020, Russian and German university scientists from SPbPU and TUHH announced a collaboration to enhance the production of astaxanthin for its antioxidant application.

Moreover, increasing studies related to the health benefits of natural astaxanthin are expected to increase the market uptake. For instance, in August 2022, a study published by the American Journal of Clinical Nutrition stated that krill oil can help manage stiffness, knee pain, and physical function in adults with osteoarthritis & knee pain between the ages of 40 and 65 years.

In addition, owing to the high demand for astaxanthin in international markets various leading players are strengthening their supply chain capabilities to make their products available. For instance, in July 2021, Atacama Bio Natural Products S.A. signed an exclusive distribution agreement with Guangzhou Carelife Food Additives Co., Ltd. to promote its distribution network in China. Moreover, in June 2022, Pharmactive Biotech Products partnership with Singapore-based Nutraconnect to introduce scientifically backed novel nutraceuticals into the Asia Pacific market.

Furthermore, supportive regulatory policies and increasing approval of products are driving the industry’s growth. For instance, in July 2021, NextFern Technologies received regulatory approval for its Astafern from Health Canada. Astafern is an innovative fermented astaxanthin antioxidant in form of gummies. In addition, the government has undertaken supportive registration requirements for carotenoid-based coloring agents and mixed feeds containing carotenoid-based coloring agents.

Request a free sample copy or view report summary: Astaxanthin Market Report

Astaxanthin Market Report Highlights

• Based on product, the dried algae meal or biomass segment accounted for the largest share in 2023 due to the high usage as animal feed and lower cost of production
• The aquaculture & animal feed segment was the highest revenue contributor in 2023. Whereas, the nutraceuticals segment is expected to exhibit the fastest CAGR during the projected period
• The Asia Pacific region is expected to grow at the fastest rate over the forecast period due to the rising investments by market players and increasing research activities in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/astaxanthin-market

Astaxanthin Market Segmentation

Grand View Research has segmented the global astaxanthin market on the basis of source, product, application, and region

Astaxanthin Source Outlook (Revenue, USD Million, 2018 - 2030) (Volumein Metric Tonnes)

• Natural
  • Yeast
  • Krill/Shrimp
  • Microalgae
  • Others
• Synthetic

Astaxanthin Product Outlook (Revenue, USD Million, 2018 - 2030)

• Dried Algae Meal or Biomass
• Oil
• Softgel
• Liquid
• Others

Astaxanthin Application Outlook (Revenue, USD Million, 2018 - 2030)

• Nutraceuticals
• Cosmetics
• Aquaculture And Animal Feed
• Food
  • Functional Foods And Beverages
  • Other Traditional Food Manufacturing Applications
• Others

Astaxanthin Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Denmark
  • Norway
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Ecuador
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Kuwait

List of Key Players of Astaxanthin Market

• Algatech Ltd
• MicroA
• Cyanotech Corporation
• Algalíf Iceland ehf
• Beijing Gingko Group (BGG)
• PIVEG, Inc.
• Fuji Chemical Industries Co., Ltd
• ENEOS Corporation
• Atacama Bio Natural Products S.A.
• I.D. – Parry (India) Limited (Alimtec S.A., Valensa International)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Dental Implants Market to Witness Soaring Growth During 2023 – 2030: Grand View Research Inc.

 Dental Implants Market Growth & Trends

The global dental implant market size is expected to reach USD 9.62 billion by 2030, registering a CAGR of 9.8% according to a new report by Grand View Research, Inc. Rising demand for tooth replacement has provided good growth potential to the market. The increasing number of dental injuries owing to road accidents and sports injuries are some of the major factors boosting the market growth.

With growing aesthetic awareness, people are exploring more treatment options, which is leading to the growth of the market. For instance, as per the American Academy of Cosmetic Dentistry data, more than 95.0% of individuals across the globe believe that their smile is a vital social asset and nearly 84.0% revealed to be under increased pressure to perfect their smile, thus increasing the product demand. Dental implants are considered the only restorative technique that preserves and stimulates natural bone. Owing to the growing number of edentulous people, the demand for prosthetics is increasing, which is expected to be one of the major impact-rendering drivers for the market.

Several industries have halted their services due to the COVID-19 pandemic. However, the dental care industry is greatly impacted by the significant decrease in elective procedures, many of which are being postponed or canceled so that hospitals can focus their resources on treating patients with COVID-19. Major Countries like the U.S and India procure raw materials and electronic components from China, which has disrupted the supply chain of many dental equipments and product manufacturers. However, with the decrease in the number of COVID-19 cases, hospitals are likely to begin scheduling elective procedures, depending on their capacity of admission and patients comfort level.

Request a free sample copy or view report summary: Dental Implant Market Report

Dental Implants Market Report Highlights

• The titanium implant type segment held the largest market share in 2020 due to its wide applications, durability, and cost-effectiveness
• Zirconia implants are anticipated to witness a lucrative growth rate over the forecast period due to better flexural strength, improved aesthetic appearance, and less corrosiveness as compared to titanium
• North America dominated the market in 2020 owing to high awareness about restorative treatments and the presence of established market players

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dental-implants-market

Dental Implants Market Segmentation

Grand View Research has segmented the dental implants market on the basis of implant type and region:

Dental Implants Implant Type Outlook (Revenue, USD Million, 2018 - 2030)

• Titanium Implants
• Zirconia Implants

Dental Implants Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Austria
  • The Netherlands
  • Poland
  • Romania
  • Czech Republic
  • Greece
  • Sweden
  • Portugal
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Dental Implants Market

• BioHorizons IPH, Inc.
• Nobel Biocare Services AG
• Zimmer Biomet Holdings, Inc.
• OSSTEM IMPLANT
• Institut Straumann AG
• Bicon, LLC
• Leader Italy
• Anthogyr SAS
• DENTIS
• DENTSPLY Sirona
• DENTIUM Co., Ltd.
• T-Plus Implant Tech. Co.
• KYOCERA Medical Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Nucleic Acid Isolation And Purification Market Growth With Worldwide Industry Analysis To 2030: Grand View Research Inc.

 Nucleic Acid Isolation And Purification Market Growth & Trends

The global nucleic acid isolation and purification market size is expected to reach USD 11.21 billion by 2030, expanding at 10.06% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing automation in industries, and technological advancements in DNA purification & isolation technologies are anticipated to drive the global market during the forecast period. In addition, the flourishing biotechnology sector in emerging economies, rising adoption of molecular diagnostics, and surging trend for precision medicine are expected to offer lucrative growth opportunities.

The demand for nucleic acid isolation and purification has risen with the COVID-19 pandemic. The demand for nucleic acid isolation and purification processes has risen enormously, not only for COVID-19 testing and confirmation purposes but also for strain confirmation, research, and analysis. However, the market is highly fragmented and competitive. In addition, there is a lack of automation and skilled professionals in the market, which paves the way for new players with disruptive technologies to grow in the market. Furthermore, the availability of NGS technology and genomic data is expected to increase the growth potential for this market.

Nucleic acid isolation and purification are used in molecular diagnostics for diagnosing a range of diseases including cancer, infectious diseases, genetic disorders, and hospital-acquired infections among others. The increasing demand for precise and reliable diagnostic kits has propelled the adoption of nucleic acid purification techniques thereby supporting market expansion. Also, recent product launches by market participants is another factor fueling NAIP technology. For instance, in January 2023, QIAGEN launched EZ2 Connect molecular diagnostics platform for automated sample processing in diagnostic laboratories.

Furthermore, the flourishing biotechnology and pharmaceutical sector has driven the demand for DNA extraction and purification technique. The technique has a fundamental role in various applications including, gene therapy development, recombinant protein production, and gene expression analysis. Also, various organic as well as inorganic developments undertaken by market participants to strengthen their business avenues are further expected to drive the global market. For instance, in March 2021 Promega Corporation launched XpressAMP reagents for RNA extraction. The newly launched reagents are automation friendly and can be used for nucleic acid purification and isolation purposes.

Request a free sample copy or view report summary: Nucleic Acid Isolation And Purification Market Report

Nucleic Acid Isolation And Purification Market Report Highlights

• In Product, the kits & reagents segment dominated the market in 2022, with a revenue share of 76.28%. The high revenue growth of the segment is owing to rising demand for kits during analysis and rising research studies
• By type, RNA isolation and purification held a larger share of 53.88% in 2022. The higher revenue share is attributed to rising molecular biology applications and increasing application of RNA isolation in the development of diagnostics
• Based on application, the diagnostics segment dominated the market with a revenue share of 33.49% in 2022. The rising application of DNA and RNA isolation for the identification of pathogens in routine sample processing is expected to drive segment expansion
• The method using magnetic beads amounted to a maximum share of 38.54% followed by the column-based method in 2022

Access Press Release@ https://www.grandviewresearch.com/press-release/global-nucleic-acid-isolation-purification-market

Nucleic Acid Isolation And Purification Market Segmentation

Grand View Research has segmented the global nucleic acid isolation and purification marketby product, type, application, method, end-use, and region:

Nucleic Acid Isolation And Purification Product Outlook (Revenue, USD Million, 2018 - 2030)

• Kits & Reagents
• Instruments

Nucleic Acid Isolation And Purification Type Outlook (Revenue, USD Million, 2018 - 2030)

• DNA Isolation & Purification
  • Genomic DNA Isolation & Purification
  • Plasmid DNA Isolation & Purification
  • Viral DNA Isolation & Purification
  • Other
• RNA Isolation & Purification
  • miRNA Isolation & Purification
  • mRNA Isolation & Purification
  • Total RNA Isolation & Purification
  • Other

Nucleic Acid Isolation And Purification Application Outlook (Revenue, USD Million, 2018 - 2030)

• Precision Medicine
• Diagnostics
• Drug Discovery & Development
• Agriculture and Animal Research
• Other Applications

Nucleic Acid Isolation And Purification Method Outlook (Revenue, USD Million, 2018 - 2030)

• Column Based
• Magnetic Beads
• Reagent Based
• Others

Nucleic Acid Isolation And Purification End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Academic Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Hospitals and Diagnostic Centers
• Others End-use

Nucleic Acid Isolation And Purification Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Nucleic Acid Isolation And Purification Market

• QIAGEN
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Danaher
• Hoffmann-La Roche Ltd
• Merck KGaA
• Agilent Technologies
• Bio-Rad Laboratories, Inc.
• Takara Bio Inc.
• Promega Corporation
• New England Biolabs
• LGC Limited
• Abcam plc
• Norgen Biotek Corp.
• AutoGen, Inc.
• Biogenuix
• PCR Biosystems, Inc.
• MagGenome
• Apical Scientific Sdn. Bhd
• MACHEREY-NAGEL GmbH & Co. KG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Chocolate Market Outlook & Future Forecast Report Till 2030

 Chocolate Market Growth & Trends

The global chocolate market size is anticipated to reach USD 156.74 billion by 2030, expanding at a CAGR of 3.7% from 2022 to 2030, according to a new report by Grand View Research, Inc. Dark chocolate's popularity is expected to grow in the coming years because it aids in the prevention of cardiac illnesses which is one of the major drivers of the market. Other applications such as chocolate milk and chocolate cake are also gaining traction globally, thus promoting the market’s growth.

Rising consumer awareness of the health benefits of chocolate as a result of a growth in the number of marketing campaigns on social media channels and television networks is expected to boost the market growth. Chocolates are associated with love, appreciation, celebration, and happiness, and so a growing number of people continue to gift chocolates on special occasions such as Christmas, Thanksgiving, and Easter which may further promote product demand during the forecast period.

Carob bars are identical to chocolate bars in terms of fat, calories, carbohydrates, and cholesterol. The absence of caffeine distinguishes it from cocoa and makes it suitable for caffeine-sensitive or intolerant individuals. Carob is naturally sweet, so it requires a very less amount of sugar to produce the final product. These factors are expected to contribute to the growth of artificial chocolates in the coming years.

Increasing demand for sugar-free, vegan, gluten-free, and organic chocolates is a major trend in the global chocolate industry. Consumers are becoming more aware of the negative impacts on health and the environment of consuming synthetic or artificial products. As a result, the majority of informed and health-conscious consumers have started preferring organic products. This trend is expected to provide an opportunity for chocolate producers to launch new products that cater to evolving consumer demands.

The volatile price of raw materials is a significant factor that impacts the cost of production in the chocolate industry, and thus the profitability of the producers. Specific weather conditions are required for the cocoa plantation. Cocoa is a delicate plant that grows in tropical climates and requires proper vegetation shade to produce higher-quality seeds, which is why its plantation is concentrated in West Africa. This factor may hinder the market growth during the projected timeframe.

Consumers in Europe demand high-quality chocolates due to growing health concerns regarding less expensive chocolates in the region and a rise in the popularity of fine cocoa. As a result, consumers in the region are willing to pay a higher price for chocolate products that satisfy their requirements. A key factor influencing the region's chocolate industry is the major shift in European consumers' purchasing behavior toward premium chocolate products. Additionally, dark chocolates are popular in the region because they constitute less sugar and exhibit a more intensely bitter flavor due to the concentration of cocoa.

Request a free sample copy or view report summary: Chocolate Market Report

Chocolate Market Report Highlights

• Artificial chocolates are estimated to be the fastest growing in the product segment owing to the rising prevalence of carob as a healthier alternative to cocoa
• Supermarkets & hypermarkets led the distribution channel segment owing to the growing number of specialty and departmental stores in developing countries such as India and China
• In 2021, Europe had the largest revenue share in the global market. The rise in demand for dark chocolate among consumers in countries including the U.K., France, and Germany is predicted to be a major contributor to regional market growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-chocolate-market

Chocolate Market Segmentation

Grand View Research has segmented the global chocolate market based on product, distribution channel, and region:

Chocolate Product Outlook (Revenue, USD Million, 2017 - 2030)

• Traditional
  • Dark
  • Milk
  • White
• Artificial

Chocolate Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• Supermarket & Hypermarket
• Convenience Store
• Online

Chocolate Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • Switzerland
  • France
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Central & South America
  • Brazil
• Middle East & Africa
  • UAE

List of Key Players of Chocolate Market

• Barry Callebaut
• Chocoladefabriken Lindt & Sprüngli AG
• Mondel?z International, Inc.
• Nestlé
• The Hershey Company
• Ferrero Group
• Mars, Incorporated
• The Australian Carob Co.
• Meiji Holdings Co., Ltd.
• Arcor

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Specialty Resins Market 2022-2030 Analysis By Leading Players, Types, Growth Factors, Demand, Opportunities, Current Trends & Predictions

 Specialty Resins Market Growth & Trends

The global specialty resins market size is expected to reach USD 12.6 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 6.3% over the forecast period. Special resins are used to produce composite materials that are widely used in load-bearing structures applications such as building & construction, marine, automotive, and aerospace owing to their properties such as super adhesiveness, high mechanical properties, and others. The demand for high-performance specialty resins is expected to witness growth from the commercial aeroplane industry as well as emerging opportunities in various applications such as water treatment and electrical & electronics.

However, the relatively high cost and labor intensity of producing advanced composites is expected to prevent these composites from penetrating into high-volume, high-price markets. Growing demand for composites from the automotive and aerospace industries, especially in Europe and North America, is expected to remain a key driver of the market. Rising fuel prices, combined with the booming commercial aviation industry, are expected to drive demand for the product in the ensuing years.

The building and construction applications segment is expected to experience significant growth. In construction, specialty resins are used as sealants, hardeners, mortars, mortars, and laminates for walls, roofs, and decking. Properties such as excellent cleaning material, low curing shrinkage, chemical resistance, low water permeability, good mechanical properties, and excellent adhesion, among other things, are predicted to drive the use of specialty resins in construction.

Growing demand in the construction industry is predicted to drive growth in the market during the forecast period. Construction is a broad industry that includes everything from mining, quarrying, and forestry to infrastructure and building construction, product manufacturing and supply, and repair, maintenance, and disposal. Specialty resin is used in the production of plastics, paints, coatings, flooring, plastics, primers and sealants, adhesives, and other building materials and components. For example, according to construction industry statistics, in 2021, the US construction sector generated $1.6 trillion in sales. The average US construction industry spends nearly $1,245 billion a year. In addition, rising awareness among the masses about the benefits of green buildings is further anticipated to fuel the growth of the construction industry globally. This, in turn, is projected to lead to a risen demand for specialty resins in construction applications over the forecast period.

Request a free sample copy or view report summary: Specialty Resins Market Report

Specialty Resins Market Report Highlights

• In terms of revenue, building & construction application segment accounted for a prominent share of more than 37.0% in the market in 2021 and is further expected to witness prominent growth over the forecast period.
• Electrical & Electronics application segment is projected to progress at a CAGR of 7.3% during the forecast period. Properties such as low shrinkage, less exothermicity during the curing process, excellent mechanical and electrical insulating properties, and increased toughness fuel the demand for specialty resins for use in electrical & electronics applications.
• As of 2021, Asia Pacific region accounted for more than 61.0%. The growing number of manufacturing facilities is boosting construction activities in the region, which, in turn, is anticipated to propel the demand for specialty resins over the forecast period.
• Strategic partnerships & agreements, capacity expansions, and new product developments are the popular strategies adopted by most market players. For instance, in September 2021, Polytek Development Corp. a portfolio company of Arsenal Capital Partners which is one of the leading specialized producers of polymers for mold forming, coating, and casting applications, acquired the Specialty Resin & Chemical.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-specialty-resins-market

Specialty Resins Market Segmentation

Grand View Research has segmented the specialty resins market report based on application, type, function and region:

Specialty Resins Application Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• Building & Construction
• Water Treatment
• Marine
• Electrical & Electronics
• Automotive
• Aerospace
• Others

Specialty Resins Type Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• Vinyl
• Epoxy
• Polyamides
• Unsaturated Polyester Resins
• Others

Specialty Resins Function Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• Protection
• Insulation
• Others

Specialty Resins Region Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK.
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa
  • Saudi Arabia
  • South Africa

List of Key Players of Specialty Resins Market

• BASF SE
• Hexion Inc.
• SABIC
• Royal DSM
• Arkema
• Radiant Color NV
• Mitsubishi Chemical Corporation
• The Dow Chemical Company
• Huntsman International LLC
• Aldex Chemical Company Limited
• Thermax Limited
• International Specialty Chemicals Ltd.
• Purolite
• Kolon Industries

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.